Quality of Antimalarial Drugs in East Africa: A Systematic Review

Quality of Antimalarial Drugs in East Africa: A Systematic Review

Million Girma,1 Belachew Umeta,2 Gemmechu Hasen,2 Sultan Suleman2,3 1School of Pharmacy, College of Medicine and Health Sciences, Wolaita Sodo University, Wolaita Sodo, Ethiopia; 2School of Pharmacy, Institute of Health, Jimma University, Jimma, Ethiopia; 3Jimma University Laboratory of Drug Quality...

Full description

Bibliographic Details
Main Authors:	Girma M, Umeta B, Hasen G, Suleman S
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-10-01
Series:	Infection and Drug Resistance
Subjects:	antimalarial drugs quality control coartem artemether/lumefantrine assay dissolution east africa
Online Access:	https://www.dovepress.com/quality-of-antimalarial-drugs-in-east-africa-a-systematic-review-peer-reviewed-fulltext-article-IDR

Similar Items

Open-label trial on efficacy of artemether/lumefantrine against the uncomplicated Plasmodium falciparum malaria in Metema district, Northwestern Ethiopia
by: Wudneh F, et al.
Published: (2016-08-01)

Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
by: Sileshi Belew, et al.
Published: (2020-04-01)

Potential Antimalarial Activity of Artemether/Lumefantrine/Doxycycline: A Study in Mice Infected with Plasmodium berghei
by: Udeme Owunari Georgewill, et al.
Published: (2022-02-01)

Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos
by: Mayxay Mayfong, et al.
Published: (2012-06-01)

Formulation, process development and evaluation of artemether and lumefantrine soft gelatin capsule
by: A Patel, et al.
Published: (2012-01-01)

Pharmaceutical quality of antimalarial drugs: quinine sulfate and Artemether/Lumefantrine tablets sold on Bukavu Market
by: Aladin Ombeni Mahano, et al.
Published: (2021-06-01)

Malaria healthcare policy change in Kenya: Implications on sales and marketing of antimalarials
by: Peter K. Ngure , Lorraine Nyaoke & David Minja
Published: (2012-03-01)

Incompatibility of antimalarial drugs: challenges in formulating combination products for malaria
by: Ellen K. G. Mhango, et al.
Published: (2024-12-01)

In vivo efficacy of artemether–lumefantrine against uncomplicated Plasmodium falciparum malaria in Dembia District, northwest Ethiopia
by: Deressa T, et al.
Published: (2017-02-01)

Smart nanocrystals of artemether: fabrication, characterization, and comparative in vitro and in vivo antimalarial evaluation
by: Shah SMH, et al.
Published: (2016-11-01)

Green Analytical Methods of Antimalarial Artemether-Lumefantrine Analysis for Falsification Detection Using a Low-Cost Handled NIR Spectrometer with DD-SIMCA and Drug Quantification by HPLC
by: Moussa Yabré, et al.
Published: (2020-07-01)

Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine and prevalence of molecular markers of anti-malarial drug resistance in children in Togo in 2021
by: Ameyo Monique Dorkenoo, et al.
Published: (2024-04-01)

Adverse reaction to Coartem (artemether/lumefantrine) resulting in oculogyric crisis
by: Emmanuel Kofi Amponsah, et al.
Published: (2021-05-01)

Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018
by: Adama Gansané, et al.
Published: (2021-01-01)

NANOPARTICLE-BASED formulation of dihydroartemisinin-lumefantrine duo-drugs: Preclinical Evaluation and enhanced antimalarial efficacy in a mouse model
by: Pesila Akeyo Odera, et al.
Published: (2024-03-01)

Artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers
by: Victor S. Koko, et al.
Published: (2022-04-01)

Therapeutic efficacy and safety of artesunate + amodiaquine and artemether + lumefantrine in treating uncomplicated Plasmodium falciparum malaria in children on the rainy south-east coast of Madagascar
by: Irinantenaina Judickaëlle, et al.
Published: (2023-01-01)

In vivo efficacy of anti-malarial drugs against clinical Plasmodium vivax malaria in Ethiopia: a systematic review and meta-analysis
by: Tsige Ketema, et al.
Published: (2021-12-01)

Comparison of malaria treatment outcome of generic and innovator’s anti-malarial drugs containing artemether–lumefantrine combination in the management of uncomplicated malaria amongst Tanzanian children
by: Manase Kilonzi, et al.
Published: (2019-04-01)

Comparison of the efficacy of artemether-lumefantrine vs. artesunate plus sulfadoxine-pyrimethamine in children with uncomplicated falciparum malaria
by: Rachmawati Rachmawati, et al.
Published: (2010-04-01)

Artemether–lumefantrin treatment adherence among uncomplicated plasmodium falciparum malaria patients, visiting public health facilities in AsgedeTsimbla district, Tigray, Ethiopia: a cross-sectional study
by: Mekonnen Gebremichael Gebrekidan, et al.
Published: (2020-11-01)

Therapeutic failure after regimen with artemether-lumefantrine combination therapy: a report of three cases in Benin City, Nigeria
by: Osamudiamen Ebohon, et al.
Published: (2019-10-01)

A randomized trial of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali
by: Souleymane Dama, et al.
Published: (2018-10-01)

Quality of fixed dose artemether/lumefantrine products in Jimma Zone, Ethiopia
by: Sileshi Belew, et al.
Published: (2019-07-01)

Need for optimized dosages in the design of comparative clinical trials of anti-malarial drugs
by: Sanjeev Krishna, et al.
Published: (2022-06-01)

Parasite clearance, cure rate, post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether–lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo district, Tanzania: a randomized controlled trial
by: Lwidiko E. Mhamilawa, et al.
Published: (2020-06-01)

A randomized clinical trial comparing safety, clinical and parasitological response to artemether-lumefantrine and chlorproguanil-dapsone in treatment of uncomplicated malaria in pregnancy in Mulago
by: Daniel Kabonge Kaye,1 Ruth Nshemerirwe,1 Twaha Serunjogi Mutyaba,1 Grace Ndeezi.2
Published: (2008-04-01)

Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria
by: Joel Tarning, et al.
Published: (2022-10-01)

Meta-Analysis of Data from Four Clinical Trials in the Ivory Coast Assessing the Efficacy of Two Artemisinin-Based Combination Therapies (Artesunate-Amodiaquine and Artemether-Lumefantrine) between 2009 and 2016
by: Akoua Valérie Bédia-Tanoh, et al.
Published: (2023-12-01)

Comparison of the physicochemical properties and in vivo bioavailability of generic and innovator artemether-lumefantrin tablets in Kumasi, Ghana
by: Noble Kuntworbe, et al.
Published: (2018-05-01)

Safety monitoring experience of single-low dose primaquine co-administered with artemether–lumefantrine among providers and patients in routine healthcare practice: a qualitative study in Eastern Tanzania
by: Dominic Mosha, et al.
Published: (2021-10-01)

Evaluation of cardiotoxicity and other adverse effects associated with concomitant administration of artemether/lumefantrine and atazanavir/ritonavir-based antiretroviral regimen in patients living with HIV
by: Sikiru Olatunji Usman, et al.
Published: (2022-05-01)

Optimal timing of primaquine to reduce Plasmodium falciparum gametocyte carriage when co-administered with artemether–lumefantrine
by: Seif Shekalaghe, et al.
Published: (2020-01-01)

Artemether-lumefantrine treatment failure of uncomplicated Plasmodium falciparum malaria in travellers coming from Angola and Mozambique
by: André Silva-Pinto, et al.
Published: (2021-09-01)

Efficacy of artemether .. lumefantrine and artesunate-amodiaquine for treating uncomplicated falciparum malaria in children
by: Tri Faranita, et al.
Published: (2012-10-01)

Efficacy and safety of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017
by: Elizabeth Davlantes, et al.
Published: (2018-04-01)

Artemisinin anti-malarial drugs in China
by: Zongru Guo
Published: (2016-03-01)

Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial
by: Jaishree Raman, et al.
Published: (2019-06-01)

Plasmodium falciparum Drug Resistance Genes pfmdr1 and pfcrt In Vivo Co-Expression During Artemether-Lumefantrine Therapy
by: M. Silva, et al.
Published: (2022-05-01)

High adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, Nanoro, Burkina Faso
by: Rouamba T, et al.
Published: (2019-02-01)